Evaluation  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
Gastroesophageal  ||| S:14 E:31 ||| NNP
Reflux  ||| S:31 E:38 ||| NNP
Disease  ||| S:38 E:46 ||| NNP
Using  ||| S:46 E:52 ||| VBG
the  ||| S:52 E:56 ||| DT
Bravo  ||| S:56 E:62 ||| NNP
Capsule  ||| S:62 E:70 ||| NNP
pH  ||| S:70 E:73 ||| NNP
System  ||| S:73 E:80 ||| NNP
Gastroesophageal  ||| S:80 E:97 ||| NNP
reflux  ||| S:97 E:104 ||| JJ
disease  ||| S:104 E:112 ||| NN
( ||| S:112 E:113 ||| -LRB-
GERD ||| S:113 E:117 ||| NNP
)  ||| S:117 E:119 ||| -RRB-
is  ||| S:119 E:122 ||| VBZ
a  ||| S:122 E:124 ||| DT
disease  ||| S:124 E:132 ||| NN
predominantly  ||| S:132 E:146 ||| RB
seen  ||| S:146 E:151 ||| VBN
in  ||| S:151 E:154 ||| IN
the  ||| S:154 E:158 ||| DT
West  ||| S:158 E:163 ||| NNP
but  ||| S:163 E:167 ||| CC
there  ||| S:167 E:173 ||| EX
is  ||| S:173 E:176 ||| VBZ
a  ||| S:176 E:178 ||| DT
rising  ||| S:178 E:185 ||| VBG
trend  ||| S:185 E:191 ||| NN
in  ||| S:191 E:194 ||| IN
Asia ||| S:194 E:198 ||| NNP
.  ||| S:198 E:200 ||| .
Ambulatory  ||| S:200 E:211 ||| JJ
24-hour  ||| S:211 E:219 ||| JJ
catheter-based  ||| S:219 E:234 ||| JJ
pH  ||| S:234 E:237 ||| JJ
monitoring  ||| S:237 E:248 ||| NN
has  ||| S:248 E:252 ||| VBZ
been  ||| S:252 E:257 ||| VBN
the  ||| S:257 E:261 ||| DT
de  ||| S:261 E:264 ||| FW
facto  ||| S:264 E:270 ||| FW
gold  ||| S:270 E:275 ||| JJ
standard  ||| S:275 E:284 ||| JJ
test  ||| S:284 E:289 ||| NN
for  ||| S:289 E:293 ||| IN
GERD  ||| S:293 E:298 ||| NNP
that  ||| S:298 E:303 ||| IN
correlates  ||| S:303 E:314 ||| JJ
symptoms  ||| S:314 E:323 ||| NNS
with  ||| S:323 E:328 ||| IN
acid  ||| S:328 E:333 ||| JJ
reflux  ||| S:333 E:340 ||| JJ
episodes ||| S:340 E:348 ||| NNS
.  ||| S:348 E:350 ||| .
However ||| S:350 E:357 ||| RB
,  ||| S:357 E:359 ||| ,
drawbacks  ||| S:359 E:369 ||| JJ
such  ||| S:369 E:374 ||| JJ
as  ||| S:374 E:377 ||| IN
patients ||| S:377 E:385 ||| NNS
'  ||| S:385 E:387 ||| POS
discomfort ||| S:387 E:397 ||| NN
,  ||| S:397 E:399 ||| ,
and  ||| S:399 E:403 ||| CC
catheter  ||| S:403 E:412 ||| JJ
displacement  ||| S:412 E:425 ||| NNS
render  ||| S:425 E:432 ||| VBP
the  ||| S:432 E:436 ||| DT
test  ||| S:436 E:441 ||| NN
as  ||| S:441 E:444 ||| IN
cumbersome  ||| S:444 E:455 ||| JJ
and  ||| S:455 E:459 ||| CC
error-prone ||| S:459 E:470 ||| JJ
.  ||| S:470 E:472 ||| .
The  ||| S:472 E:476 ||| DT
Bravo  ||| S:476 E:482 ||| NNP
pH  ||| S:482 E:485 ||| JJ
wireless  ||| S:485 E:494 ||| JJ
system  ||| S:494 E:501 ||| NN
is  ||| S:501 E:504 ||| VBZ
designed  ||| S:504 E:513 ||| VBN
to  ||| S:513 E:516 ||| TO
be  ||| S:516 E:519 ||| VB
user-friendly  ||| S:519 E:533 ||| JJ
and  ||| S:533 E:537 ||| CC
has  ||| S:537 E:541 ||| VBZ
an  ||| S:541 E:544 ||| DT
added  ||| S:544 E:550 ||| JJ
advantage  ||| S:550 E:560 ||| NN
of  ||| S:560 E:563 ||| IN
prolonged  ||| S:563 E:573 ||| JJ
pH  ||| S:573 E:576 ||| JJ
monitoring ||| S:576 E:586 ||| NN
.  ||| S:586 E:588 ||| .
The  ||| S:588 E:592 ||| DT
system  ||| S:592 E:599 ||| NN
is  ||| S:599 E:602 ||| VBZ
comparable  ||| S:602 E:613 ||| JJ
to  ||| S:613 E:616 ||| TO
the  ||| S:616 E:620 ||| DT
catheter-based  ||| S:620 E:635 ||| JJ
pH  ||| S:635 E:638 ||| JJ
monitoring  ||| S:638 E:649 ||| NN
system  ||| S:649 E:656 ||| NN
in  ||| S:656 E:659 ||| IN
terms  ||| S:659 E:665 ||| NNS
of  ||| S:665 E:668 ||| IN
diagnostic  ||| S:668 E:679 ||| JJ
yield  ||| S:679 E:685 ||| NN
and  ||| S:685 E:689 ||| CC
symptom-reflux  ||| S:689 E:704 ||| JJ
association ||| S:704 E:715 ||| NN
.  ||| S:715 E:717 ||| .
Indications  ||| S:717 E:729 ||| NNS
include  ||| S:729 E:737 ||| VBP
evaluation  ||| S:737 E:748 ||| NN
of  ||| S:748 E:751 ||| IN
patients  ||| S:751 E:760 ||| NNS
with  ||| S:760 E:765 ||| IN
refractory  ||| S:765 E:776 ||| JJ
GERD  ||| S:776 E:781 ||| NN
symptoms  ||| S:781 E:790 ||| NNS
and  ||| S:790 E:794 ||| CC
prior  ||| S:794 E:800 ||| RB
to  ||| S:800 E:803 ||| TO
anti-reflux  ||| S:803 E:815 ||| JJ
surgery ||| S:815 E:822 ||| NN
.  ||| S:822 E:824 ||| .
Bravo  ||| S:824 E:830 ||| NNP
utilizes  ||| S:830 E:839 ||| VBD
a  ||| S:839 E:841 ||| DT
wireless  ||| S:841 E:850 ||| JJ
pH-sensing  ||| S:850 E:861 ||| JJ
capsule  ||| S:861 E:869 ||| NN
with  ||| S:869 E:874 ||| IN
a  ||| S:874 E:876 ||| DT
complete  ||| S:876 E:885 ||| JJ
prepackaged  ||| S:885 E:897 ||| JJ
system ||| S:897 E:903 ||| NN
,  ||| S:903 E:905 ||| ,
and  ||| S:905 E:909 ||| CC
a  ||| S:909 E:911 ||| DT
data  ||| S:911 E:916 ||| NN
processing  ||| S:916 E:927 ||| NN
software ||| S:927 E:935 ||| NN
.  ||| S:935 E:937 ||| .
The  ||| S:937 E:941 ||| DT
capsule  ||| S:941 E:949 ||| NN
may  ||| S:949 E:953 ||| MD
be  ||| S:953 E:956 ||| VB
positioned  ||| S:956 E:967 ||| VBN
indirectly  ||| S:967 E:978 ||| RB
using  ||| S:978 E:984 ||| VBG
endoscopic  ||| S:984 E:995 ||| NNS
or  ||| S:995 E:998 ||| CC
manometric  ||| S:998 E:1009 ||| JJ
landmarks  ||| S:1009 E:1019 ||| NN
or  ||| S:1019 E:1022 ||| CC
under  ||| S:1022 E:1028 ||| IN
direct  ||| S:1028 E:1035 ||| JJ
endoscopic  ||| S:1035 E:1046 ||| JJ
guidance ||| S:1046 E:1054 ||| NN
.  ||| S:1054 E:1056 ||| .
Optimal  ||| S:1056 E:1064 ||| JJ
threshold  ||| S:1064 E:1074 ||| NN
cut-off  ||| S:1074 E:1082 ||| JJ
values  ||| S:1082 E:1089 ||| NNS
are  ||| S:1089 E:1093 ||| VBP
yet  ||| S:1093 E:1097 ||| RB
to  ||| S:1097 E:1100 ||| TO
be  ||| S:1100 E:1103 ||| VB
standardized  ||| S:1103 E:1116 ||| JJ
but  ||| S:1116 E:1120 ||| CC
based  ||| S:1120 E:1126 ||| VBN
on  ||| S:1126 E:1129 ||| IN
available  ||| S:1129 E:1139 ||| JJ
studies ||| S:1139 E:1146 ||| NNS
,  ||| S:1146 E:1148 ||| ,
for  ||| S:1148 E:1152 ||| IN
the  ||| S:1152 E:1156 ||| DT
Asian  ||| S:1156 E:1162 ||| JJ
population ||| S:1162 E:1172 ||| NN
,  ||| S:1172 E:1174 ||| ,
it  ||| S:1174 E:1177 ||| PRP
may  ||| S:1177 E:1181 ||| MD
be  ||| S:1181 E:1184 ||| VB
recommended  ||| S:1184 E:1196 ||| VBN
for  ||| S:1196 E:1200 ||| IN
total  ||| S:1200 E:1206 ||| JJ
%  ||| S:1206 E:1208 ||| NN
time  ||| S:1208 E:1213 ||| NN
pH  ||| S:1213 E:1216 ||| JJ
< ||| S:1216 E:1218 ||| SYM
4  ||| S:1218 E:1220 ||| CD
of  ||| S:1220 E:1223 ||| IN
5.8  ||| S:1223 E:1227 ||| CD
over  ||| S:1227 E:1232 ||| IN
48  ||| S:1232 E:1235 ||| CD
hours ||| S:1235 E:1240 ||| NNS
.  ||| S:1240 E:1242 ||| .
Cost  ||| S:1242 E:1247 ||| NN
is  ||| S:1247 E:1250 ||| VBZ
a  ||| S:1250 E:1252 ||| DT
limitation  ||| S:1252 E:1263 ||| NN
but  ||| S:1263 E:1267 ||| CC
capsule  ||| S:1267 E:1275 ||| JJ
placement  ||| S:1275 E:1285 ||| NN
is  ||| S:1285 E:1288 ||| VBZ
relatively  ||| S:1288 E:1299 ||| RB
safe  ||| S:1299 E:1304 ||| JJ
although  ||| S:1304 E:1313 ||| IN
technical  ||| S:1313 E:1323 ||| JJ
failures  ||| S:1323 E:1332 ||| NNS
may  ||| S:1332 E:1336 ||| MD
be  ||| S:1336 E:1339 ||| VB
seen  ||| S:1339 E:1344 ||| VBN
in  ||| S:1344 E:1347 ||| IN
small  ||| S:1347 E:1353 ||| JJ
percentage  ||| S:1353 E:1364 ||| NN
of  ||| S:1364 E:1367 ||| IN
cases ||| S:1367 E:1372 ||| NNS
.  ||| S:1372 E:1374 ||| .
